SPONSOR
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Total Trials
15
Recruiting
15
Phases
Phase 2, Phase 3, Phase 4, Phase 3, Phase 2
Conditions studied: CancerNeoplasmWrinkleGlabellar Frown LinesGlabellar FurrowingModerate-to-severe Atopic EczemaAtopic DermatitisAtopic Dermatitis EczemaCarcinoma, Squamous CellOesophageal Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Cancer, Neoplasm, Wrinkle, Glabellar Frown Lines.
The trial portfolio spans Phase 2, Phase 3, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
How many clinical trials has Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), of which 15 are actively recruiting participants. These trials cover conditions including Cancer, Neoplasm, Wrinkle. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) research focus on?
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) clinical trials span Cancer, Neoplasm, Wrinkle, Glabellar Frown Lines, Glabellar Furrowing, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) clinical trial?
To participate in a Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials with current recruitment status updated daily.
Clinical Trials by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT06672887 Phase 2, Phase 3
Recruiting
Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
Cancer
NCT06448676 Phase 4
Recruiting
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Wrinkle
NCT03621137
Recruiting
TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies
Moderate-to-severe Atopic Eczema
NCT06004986 Phase 4
Recruiting
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Atopic Dermatitis
NCT04481256
Recruiting
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
Carcinoma, Squamous Cell
NCT06888999
Recruiting
In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints
Return to Work
NCT05783804
Recruiting
Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
Coronary Artery Disease Progression
NCT05924555
Recruiting
Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders
Long-chain Fatty Acid Oxidation Disorders
NCT07359482 Phase 3
Recruiting
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Post-COVID
NCT06059989 Phase 3
Recruiting
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Inflammatory Disease
NCT05344612
Recruiting
Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD
Chest Pain
NCT04776642
Recruiting
Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
Arrythmia
NCT06940011 Phase 2
Recruiting
Endocalyx in Treatment Resistent Hypertension
Treatment Resistant Hypertension
NCT05139589
Recruiting
The ENDOCARDITIS AUMC Data Collection
Endocarditis
NCT07020104
Recruiting
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
Chronic Kidney Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology